Cergutuzumab amunaleukin
CAS: 1509916-03-3
Ref. TM-T76944
| 1mg | 389.00 € | ||
| 5mg | 989.00 € | ||
| 10mg | 1,615.00 € | ||
| 25mg | 2,385.00 € | ||
| 50mg | 3,238.00 € |
Estimated delivery in United States, on Monday 30 Dec 2024
Product Information
Name:
Cergutuzumab amunaleukin
Synonyms:
- RG 7813
- CEA-IL2v
- RO 6895882
Description:
Cergutuzumab amunaleukin (CEA-IL2v) is a CEA-targeted IL-2 variant immunocytokine for combination cancer immunotherapy with anti-tumor activity.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
162.05 kDa
Purity:
SDS-PAGE: 98.0%；SEC-HPLC: 99.7% - SDS-PAGE:98.0%;SEC-HPLC:99.7%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T76944 Cergutuzumab amunaleukin
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
